13F-HR filed by Velan Capital Investment Management LP
Velan Capital Investment Management LP filed this 13F-HR for the quarter ended 2023-06-30, filed 2023-08-11, with 31 holding rows worth $107,698,566.
- Accession
- 0001848809-23-000003
- Filer
- CIK 1848809
- Filed
- 2023-08-11
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2023
A holdings report, 32 entries on the cover page, a total value of $107,698,566 stated on the cover page (in dollars after the unit check, H1), rows summing to $107,698,566 with VALUE read as dollars as filed, 13F file number 028-21996. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| JASPER THERAPEUTICS INC | 471871103 | COM | 11,219,036 | $14,848,445 | dollars as filed | |
| ADMA BIOLOGICS INC | 000899104 | COM | 2,726,051 | $10,059,128 | dollars as filed | |
| LANTHEUS HLDGS INC | 516544103 | COM | 100,000 | $8,392,000 | dollars as filed | |
| TELA BIO INC | 872381108 | COM | 746,087 | $7,557,861 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W108 | COM | 5,185,000 | $5,962,750 | dollars as filed | |
| HERON THERAPEUTICS INC | 427746102 | COM | 4,500,000 | $5,220,000 | dollars as filed | |
| QUIPT HOME MEDICAL CORP | 74880P104 | COM | 970,000 | $5,179,800 | dollars as filed | |
| ALIMERA SCIENCES INC | 016259202 | COM | 1,659,654 | $4,846,190 | dollars as filed | |
| OPTINOSE INC | 68404V100 | COM | 3,596,861 | $4,424,139 | dollars as filed | |
| TENET HEALTHCARE CORP COM NEW | 88033G407 | Stock | 51,900 | $4,223,622 | dollars as filed | |
| IMMUNOGEN INC | 45253H101 | COMMON STOCK | 189,500 | $3,575,865 | dollars as filed | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 250,000 | $3,227,500 | dollars as filed | |
| GALERA THERAPEUTICS EQUICLASS EQUITY | 36338D108 | COMMON STOCK | 1,000,000 | $3,120,000 | dollars as filed | |
| POINT BIOPHARMA GLOBAL INC | 730541109 | COM | 342,936 | $3,107,000 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 55,300 | $2,820,300 | dollars as filed | |
| GERON CORP | 374163103 | COM | 778,500 | $2,498,985 | dollars as filed | |
| INSPIREMD INC | 45779A846 | COM | 904,029 | $2,269,113 | dollars as filed | |
| CATALENT INC USD 0.01 | 148806102 | COM | 50,000 | $2,168,000 | dollars as filed | |
| 89BIO INC | 282559103 | COM | 95,000 | $1,800,250 | dollars as filed | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 240,000 | $1,689,600 | dollars as filed | |
| AVADEL PHARMACEUTICALS, PLC | 05337M104 | COMMON STOCK-FO | 100,000 | $1,648,000 | dollars as filed | |
| ANNEXON INC | 03589W102 | COM | 459,746 | $1,618,306 | dollars as filed | |
| ICOSAVAX INC | 45114M109 | COM | 160,630 | $1,595,056 | dollars as filed | |
| EDESA BIOTECH INC | 27966L108 | COM | 1,281,615 | $1,039,262 | dollars as filed | |
| Inflarx Nv | N44821101 | COM | 200,000 | $892,000 | dollars as filed | |
| REZOLUTE INC | 76200L309 | COMMON STOCK | 400,000 | $792,000 | dollars as filed | |
| ELEVATION ONCOLOGY INC COM | 28623U101 | Stock | 497,299 | $755,894 | dollars as filed | |
| INHIBRX INC | 45720L107 | COM | 25,000 | $649,000 | dollars as filed | |
| AIRSCULPT TECHNOLOGIES INC | 009496100 | COMMON STOCK | 75,000 | $646,500 | dollars as filed | call |
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 50,000 | $538,000 | dollars as filed | |
| QUIPT HOME MEDICAL CORP | 74880P104 | COM | 100,000 | $534,000 | dollars as filed | call |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001848809-23-000003 | this filing | 2023-08-11 | acceptance time not in the bulk data set |